Genentech Misstates Breast Cancer Drug Amount, Suit Says
Biotechnology firm Genentech shortchanges health providers on breast cancer drugs, a Long Island medical practice alleged in a lawsuit filed Tuesday in New York federal court....To view the full article, register now.
Already a subscriber? Click here to view full article